Announcements Trials
Browse Landscape

Phase

Phase 2 105Phase 3 101Phase 1/2 42Phase 1 41Phase 2/3 11Phase NA 5Phase 4 1

Status

Recruiting 3Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 4CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Lung Neoplasms 2NSCLC 1Meningeal Carcinomatosis 1Lymphatic Metastasis 1Carcinoma 1

Interventions

Standard of Care 172Blood Specimen Collection 133Exercise 121Educational Status 113Methods 107Surveys and Questionnaires 104Practice Guidelines as Topic 104Interviews as Topic 103Early Intervention, Educational 92Magnetic Resonance Spectroscopy 79Specimen Handling 74Radiosurgery 67Radiotherapy 56Palliative Care 48Biopsy 40Patient Navigation 37Control Groups 35Drug Therapy 32Therapeutics 31Resistance Training 31Surgical Procedures, Operative 30Diet Therapy 30Behavior Therapy 29Counseling 28Proton Therapy 25Acupuncture Therapy 25Exercise Test 24Nutrition Assessment 23Magnetic Resonance Imaging 23Radiation 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase NA × Pemetrexed × 1 year × Clear all
NCT02194738 2026-05-13

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

National Cancer Institute (NCI)

Phase NA Active not recruiting
8,300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07538193 2026-04-20

Iparomlimab and Tuvonralimab Plus Chemotherapy Before Surgery for Stage III Lung Cancer

Tang-Du Hospital

Phase NA Not yet recruiting
28 enrolled
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lymphatic Metastasis

NCT06484491 2026-01-30

HyDose

University Medical Center Groningen

Phase NA Recruiting
87 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06576635 2026-01-20

LUNG-05

University of Illinois at Chicago

Phase NA Recruiting
29 enrolled
Thoracic

NSCLC

NCT06304441 2025-09-29

Intra-pemetrexed Plus Third-generation Small Molecule TKI Drugs (e.g. 'Osimertinib') Versus Third-generation Small Molecule TKI Drugs Alone for Leptomeningeal Metastasis From Epidermal Growth Factor Receptor Mutation-Positive Non-Small-cell Lung Cancer

Guangzhou Medical University

Phase NA Recruiting
100 enrolled
CNS

Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡